BlackRock’s Urovant Sciences Ltd. UROV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-24,668
| Closed | -$398K | – | 5294 |
|
|
2020
Q4 | $398K | Sell |
24,668
-46,718
| -65% | -$754K | ﹤0.01% | 4301 |
|
|
2020
Q3 | $667K | Sell |
71,386
-238,720
| -77% | -$2.23M | ﹤0.01% | 4109 |
|
|
2020
Q2 | $3.05M | Buy |
310,106
+4,617
| +2% | +$45.4K | ﹤0.01% | 3627 |
|
|
2020
Q1 | $2.82M | Buy |
305,489
+15,219
| +5% | +$140K | ﹤0.01% | 3490 |
|
|
2019
Q4 | $4.5M | Buy |
290,270
+4,730
| +2% | +$73.4K | ﹤0.01% | 3487 |
|
|
2019
Q3 | $2.7M | Buy |
285,540
+2,065
| +0.7% | +$19.5K | ﹤0.01% | 3608 |
|
|
2019
Q2 | $2.24M | Buy |
283,475
+1,183
| +0.4% | +$9.36K | ﹤0.01% | 3684 |
|
|
2019
Q1 | $2.84M | Buy |
282,292
+51,173
| +22% | +$514K | ﹤0.01% | 3548 |
|
|
2018
Q4 | $1.52M | Sell |
231,119
-150,000
| -39% | -$988K | ﹤0.01% | 3728 |
|
|
2018
Q3 | $4.57M | Buy |
+381,119
| New | +$4.57M | ﹤0.01% | 3481 |
|